Home › Funds › Patient Capital Management, LLC › GENI

Patient Capital Management, LLC position in GENI

GENIUS SPORTS LIMITED · Consumer Discretionary

Patient Capital Management, LLC reported holding 212,819 shares of GENI (GENIUS SPORTS LIMITED) in its Q3 2026 13F filing — a position valued at US$1.2M, representing 0.04% of its reported portfolio and ranking #36 among its reported holdings. Patient Capital Management, LLC has disclosed GENI holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)212.82K sh
Reported value held$1.22M
Portfolio Weight0.04%
First reportedQ2 2026
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Patient Capital Management, LLC's GENI position evolved

Patient Capital Management, LLC first disclosed a stake in GENI in Q2 2026 at 812,819 shares (US$4.9M). Across 2 filings, Patient Capital Management, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 212,819 shares valued at US$1.2M — a reduction of -600,000 shares quarter over quarter.. Notable position changes include a 74% trim in Q3 2026 (shares rose 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 812.82K $4.93M New
Q3 2026 212.82K $1.22M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GENI and 13F data

GENI (GENIUS SPORTS LIMITED) is a Consumer Discretionary company. 22 other funds we track also report a position in GENI — the largest reported positions include Senvest Management, LLC (US$96.2M), GLENVIEW CAPITAL MANAGEMENT, LLC (US$81.8M), SHAPIRO CAPITAL MANAGEMENT LLC (US$56.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GENI

All GENI fund holders →

FAQ

How long has Patient Capital Management, LLC held GENI?

Patient Capital Management, LLC has disclosed GENI holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Patient Capital Management, LLC's current position in GENI?

As of Q3 2026, Patient Capital Management, LLC holds 212.82K shares of GENI (GENIUS SPORTS LIMITED), valued at $1.22M, representing 0.04% of its reported portfolio and ranking #36.

Has Patient Capital Management, LLC been buying or selling GENI?

In the latest 13F filing (Q3 2026), Patient Capital Management, LLC reduced its position in GENI.

Which other funds hold GENI?

Other major institutional holders of GENI include Senvest Management, LLC, GLENVIEW CAPITAL MANAGEMENT, LLC, SHAPIRO CAPITAL MANAGEMENT LLC, among 22 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.